RI
RTW Investments Portfolio holdings
AUM
$7.02B
1-Year Return
28.16%
This Quarter Return
+13.86%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.87B
AUM Growth
+$407M
(+28%)
Cap. Flow
+$367M
Cap. Flow
% of AUM
19.6%
Top 10 Holdings %
Top 10 Hldgs %
60.38%
Holding
58
New
8
Increased
29
Reduced
10
Closed
6
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$98.8M |
| 2 |
Stoke Therapeutics
STOK
|
$92.6M |
| 3 |
Milestone Pharmaceuticals
MIST
|
$91M |
| 4 |
Sarepta Therapeutics
SRPT
|
$40.4M |
| 5 |
Illumina
ILMN
|
$30.2M |
Top Sells
| 1 |
LivaNova
LIVN
|
$42.3M |
| 2 |
SI-BONE Inc
SIBN
|
$23.9M |
| 3 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$20.4M |
| 4 |
Wave Life Sciences
WVE
|
$17M |
| 5 |
Arrowhead Research
ARWR
|
$10.8M |
Sector Composition
| 1 | Healthcare | 94.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMMB
51
Chemomab Therapeutics
CMMB
$15.9M
| $233K | 0.01% |
811
-133
| -14% | -$38.2K |
|
52
electroCore
ECOR
$38.2M
| – | – |
-34,569
| Closed | -$3.63M |
|
|
53
LivaNova
LIVN
$3.14B
| – | – |
-435,136
| Closed | -$42.3M |
|
|
IMDX
54
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$73M
| – | – |
-64,444
| Closed | -$5.09M |
|
|
55
SI-BONE Inc
SIBN
$698M
| – | – |
-1,269,194
| Closed | -$23.9M |
|
|
56
Wave Life Sciences
WVE
$1.24B
| – | – |
-436,777
| Closed | -$17M |
|
|
CNCE
57
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-1,688,448
| Closed | -$20.4M |
|